In the early stages of cancer progression, the expression of Cav-1 is reduced and may has a primarily anticancer role; in the late stage, Cav-1 expression is positively correlated with tumor progression, multidrug resistance and metastasis 26, 27. The gene discussed is CAV1; the disease is neoplasm.